overlap
epitop
b
constitut
one
site
epitop
c
jhm
strain
neurotrop
member
coronavirida
tyrrel
et
al
appropri
condit
use
attenu
temperatur
sensit
mutant
demyelin
result
weiner
stohlman
weiner
knobler
et
al
knobler
et
al
investig
parallel
human
demyelin
disord
unknown
etiolog
maugh
studi
shown
demyelin
infect
direct
effect
viru
infect
oligodendrocyt
weiner
lampert
et
al
knobler
et
al
effect
normal
mask
acut
infect
neuron
infect
result
fulmin
encephalomyel
weiner
stohlman
weiner
despit
eleg
morpholog
studi
sever
laboratori
weiner
lampert
et
al
nagashima
et
al
sorensen
et
ah
knobler
et
cd
detail
understand
factor
influenc
virusinduc
demyelin
still
lack
mhv
virion
contain
helic
nucleocapsid
compos
x
rel
molecular
weight
ilf
singlestrand
messag
sens
rna
k
x
nucleocapsid
n
protein
siddel
et
sturman
holm
addit
n
protein
virion
contain
two
glycoprotein
term
el
sturman
holm
structur
model
incorpor
el
mhv
virion
recent
propos
sturman
et
sturman
holm
larg
glycoprotein
associ
virion
peplom
contain
nlink
oligosaccharid
compos
least
two
relat
polypeptid
sturman
holm
wege
et
al
bond
et
siddel
intracellular
glycosyl
precursor
polypeptid
describ
siddel
et
al
siddel
apoprotein
rottier
et
el
glycoprotein
contain
olink
oligosaccharid
niemann
klenk
holm
et
al
appear
embed
membran
avail
evid
suggest
el
interact
intern
n
protein
sturman
et
virion
glycosyl
nonglycosyl
form
el
protein
exist
wege
et
c
siddel
et
al
rottier
et
monoclon
antibodi
mab
gener
laboratori
structur
protein
mab
use
previou
studi
assign
attach
fusion
activ
viru
glycoprotein
collin
et
al
order
precis
defin
structur
el
glycoprotein
perform
competit
enzym
immunoassay
defin
epitop
associ
previous
describ
biolog
activ
glycoprotein
viru
cell
cultur
murin
hepat
origin
obtain
dr
lesli
p
weiner
collin
et
al
routin
propag
assay
laboratori
cell
previous
describ
collin
et
al
cell
infect
moi
incub
extens
syncytium
format
observ
hr
serv
sourc
viral
antigen
immunoblot
eia
assay
describ
mab
structur
protein
describ
previous
collin
et
ul
viru
neutral
assay
passiv
protect
studi
perform
describ
buchmeier
et
al
western
immunoblot
addit
immunoprecipit
collin
et
al
specif
mab
defin
western
immunoblot
towbin
et
al
techniqu
cytosol
extract
infect
control
uninfect
cell
prepar
modif
previous
describ
method
collin
et
al
infect
control
cultur
x
cell
wash
rins
buffer
mm
trishcl
ph
mm
nacl
mm
caclz
mm
mgclz
solubil
min
icecold
lysi
buffer
rins
buffer
vv
vv
glycerol
vv
aprotinin
cell
debri
pellet
g
min
cytosol
obtain
centrifug
q
min
protein
separ
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
acrylamid
separ
gel
laemmli
nitrocellulos
replica
prepar
electrophoret
transfer
hr
vcm
previous
describ
erickson
et
al
quantit
transfer
even
high
molecular
weight
protein
achiev
follow
transfer
nitrocellulos
satur
incub
min
wv
bovin
serum
albumin
pb
vv
wv
sodium
deoxychol
vv
normal
goat
serum
strip
incub
hr
hybridoma
cell
supernat
dilut
fourfold
buffer
wash
three
time
pb
vv
tween
bound
antibodi
detect
incub
hr
ilabel
affinitypurifi
goat
antibodi
mous
ig
buchmeier
et
cal
sp
act
ipg
cpm
per
gel
lane
strip
wash
dri
autoradiograph
coupl
horseradish
peroxidas
hrp
mono
antibodi
immunoglobulin
fraction
isol
ascit
fluid
precipit
equal
volum
satur
ammonium
sulfat
ph
overnight
dialysi
three
chang
sodium
carbon
buffer
ph
immunoglobulin
ig
concentr
estim
radial
immunodiffus
goat
antimous
igg
meloy
laboratori
springfield
va
antibodi
coupl
hrp
sigma
st
loui
mo
period
method
wilson
nakan
store
equal
volum
glycerol
techniqu
previous
talbot
et
al
shown
coval
coupl
averag
one
enzym
molecul
per
immunoglobulin
via
secondari
amino
group
wilson
nakan
enzym
immunoassay
eia
solidphas
immunoassay
principl
employ
microtit
plate
use
throughout
preliminari
studi
talbot
salmi
unpublish
show
certain
subcellular
fraction
infect
cell
could
use
antigen
solid
phase
particul
fraction
prepar
uninfect
mhvbinfect
cell
follow
cell
scrape
flask
wash
three
time
cold
dulbecco
phosphat
buffer
salin
ph
pb
resuspend
buffer
x
cellsml
cell
suspens
disrupt
five
cycl
rapid
freez
thaw
follow
two
cycl
sonic
ice
slurri
microtip
maximum
energi
probetyp
sonic
heat
systemsultrason
inc
plainview
n
cellular
debri
remov
centrifug
g
min
particul
materi
pellet
g
min
pellet
resuspend
pb
sonic
protein
concentr
determin
lowri
et
al
use
bovin
serum
albumin
standard
antigen
store
presenc
mm
merthiol
microtit
plate
linbro
titertek
flow
laboratori
cat
coat
mlwell
viral
control
antigen
total
protein
concentr
pgml
overnight
antigen
coat
room
temperatur
free
bind
site
polystyren
well
block
mlwell
eia
diluent
pb
supplement
vv
heatinactiv
fetal
calf
serum
vv
tween
mm
merthiol
incub
least
hr
room
temperatur
antigenco
plate
use
antibodi
bind
competit
bind
assay
antibodi
bind
assay
serial
twofold
dilut
monoclon
antibodi
ascit
fluid
incub
antigenco
plate
min
room
temperatur
incub
temperatur
subsequ
step
well
plate
wash
three
time
wash
solut
pb
supplement
vv
tween
hrplabel
affinitypurifi
antibodi
mous
igg
igm
boehringermannheim
biochem
indianapoli
ind
ad
min
incub
plate
wash
ml
substrat
solut
consist
mm
hydrogen
peroxid
mm
ophenylenediamin
msodium
citrat
buffer
ph
ad
well
enzym
reaction
termin
min
incub
subdu
light
ad
ml
nhcl
well
optic
densiti
read
od
titertek
multiskan
photomet
manufactur
eflab
helsinki
finland
competit
bind
assay
perform
follow
modif
min
incub
fourfold
dilut
ascit
sampl
contain
differ
mab
one
gentl
wash
cycl
perform
previous
determin
optim
amount
hrpconjug
mab
ad
plate
volum
ml
well
min
incub
plate
wash
three
time
substrat
ad
read
sinc
nonspecif
bind
individu
conjug
vari
consider
bind
control
antigen
taken
repres
background
bind
conjug
viral
antigen
maximum
bind
differ
taken
repres
bind
rel
inhibit
compet
first
antibodi
normal
scale
individu
test
polypeptid
specif
mono
antibodi
polypeptid
specif
monoclon
antibodi
initi
character
immunoprecipit
radiolabel
viral
protein
infect
cell
extract
collin
et
specif
could
assign
base
upon
predomin
polypeptid
immunoprecipit
coprecipit
viral
polypeptid
occasion
observ
ambigu
elimin
immunoblot
techniqu
illustr
fig
monoclon
antibodi
glycoprotein
react
virusspecif
polypeptid
migrat
approxim
well
high
molecular
weight
aggreg
penetr
separ
gel
wege
et
al
siddel
et
al
enzp
w
immunoassay
mab
glycoproteim
compar
studi
indic
membraneenrich
fraction
prepar
virusinfect
cell
provid
optim
antigen
sourc
antibodi
show
bind
characterist
antigen
prepar
equival
bind
purifi
virion
talbot
salmi
unpublish
minimum
antigen
concentr
pg
total
protein
per
well
provid
maximum
antibodi
bind
three
class
antibodi
examin
select
use
throughout
studi
fig
bind
characterist
mab
glycoprotein
determin
parallel
solidphas
eia
titrat
use
singl
antigen
prepar
bind
curv
typic
antibodi
present
fig
antibodi
appear
bind
high
avid
viral
glycoprotein
sinc
maxim
level
measur
bind
reach
frankel
gerhard
stone
nowinski
massey
schochetman
molecular
topographi
epitop
glycoprotein
competitim
bind
eia
initi
attempt
defin
topographi
antigen
site
glycoprotein
made
use
convent
solidphas
competit
radioimmunoassay
radioiodin
mab
howev
bind
effici
mani
purifi
mab
diminish
follow
radiolabel
hand
mab
retain
bind
properti
conjug
peroxidas
wilson
nakan
thu
allow
use
sensit
enzymelink
immunoassay
format
monoclon
antibodi
describ
tabl
conjug
obtain
mab
conjug
lower
eia
titer
ad
higher
concentr
bind
could
inhibit
lesser
extent
unconjug
homolog
antibodi
thu
decreas
sensit
assay
reason
conjug
provid
reliabl
probe
competit
bind
assay
nevertheless
avail
antibodi
test
unconjug
compet
antibodi
figur
show
absenc
nonspecif
block
competit
bind
assay
sinc
none
glycoprotein
antibodi
inhibit
bind
antibodi
probe
n
protein
two
major
antigen
region
could
distinguish
small
glycoprotein
el
fig
one
site
design
c
el
defin
monoclon
antibodi
none
mab
test
five
el
eight
three
n
block
bind
probe
homolog
inhibit
observ
fig
anoth
site
defin
el
antibodi
show
intermedi
level
reciproc
competit
fig
b
intermedi
block
could
indic
structur
close
possibl
overlap
epitop
gener
mutual
incomplet
steric
hindranc
upon
antibodi
bind
henc
assign
epitop
mab
epitop
b
stress
uncertainti
target
epitop
could
precis
assign
sinc
reliabl
hrpconjug
probe
antibodi
obtain
inhibit
conjug
observ
four
antigen
site
could
assign
larg
glycoprotein
fig
site
defin
two
antibodi
control
cell
control
curv
obtain
antibodi
show
minim
deviat
mean
curv
shown
bound
antibodi
detect
hrplabel
goat
antimous
ig
describ
text
immunoglobulin
concentr
pg
repres
total
amount
unconjug
antibodi
ad
glycoprotein
fig
b
site
b
c
respect
defin
antibodi
homolog
block
observ
antigen
determin
fig
site
defin
four
nonneutr
antibodi
could
compet
antibodi
bind
site
b
c
data
shown
studi
monoclon
antibodi
direct
structur
glycoprotein
use
competit
bind
immunoassay
identifi
antigeni
region
glycopeptid
yewdel
gerhard
base
data
biolog
activ
monoclon
antibodi
studi
abl
associ
specif
properti
epitop
three
nonoverlap
antigen
site
design
b
c
defin
glycoprotein
four
neutral
antibodi
site
b
c
identifi
bind
respect
two
antibodi
direct
site
compet
pair
examin
reciproc
competit
assay
member
combin
conjug
turn
minim
effect
differ
avid
stone
nowinski
result
present
interest
paradox
antibodi
direct
site
c
neutral
viru
effici
vitro
fail
studi
protect
mice
lethal
viru
chalil
bei
pg
lmmunoglobulin
fig
competit
bind
eia
hrpconjug
monoclon
antibodi
direct
glycoprotein
assay
done
describ
legend
fig
enzymeconjug
antibodi
direct
l
v
b
c
n
leng
wivo
buchmeier
et
wherea
three
neutral
antihodi
protect
wivo
mab
direct
two
topograph
distinct
antigen
site
design
b
indic
presenc
multipl
topograph
distinct
region
associ
viru
attach
host
cell
preliminari
studi
indic
antigen
variat
site
b
c
detect
variou
mhv
strain
talbot
buchmeier
unpublish
two
antigen
site
may
conformationdepend
determin
sinc
reactiv
lost
sd
denatur
western
immunoblot
tabl
made
assumpt
antigen
site
b
c
give
rise
neutral
antibodi
freeli
access
extern
milieu
four
nonneutr
antibodi
shown
solidphas
eia
bind
viral
protein
distinct
site
site
design
sinc
affect
antibodi
bind
antigen
site
b
c
definit
character
await
develop
reliabl
conjug
antibodi
bind
curv
nonneutr
antibodi
similar
neutral
antibodi
suggest
failur
neutral
due
gross
differ
titer
bind
avid
nonneutr
antibodi
viral
attach
protein
demonstr
retrovirus
massey
schochetman
bruck
et
ak
togavirus
roehrig
et
kimurakuroda
yasui
orthomyxovirus
breschkin
et
al
carter
et
rhabdovirus
volk
et
al
reovirus
burstin
et
found
antibodi
el
fail
neutral
vitro
also
alter
diseas
process
tivo
buchmeier
et
al
contrast
nonneutr
mab
sindbi
viru
prevent
lethal
enceph
viva
schmaljohn
et
uk
glycoprotein
el
contain
least
three
epitop
design
el
b
el
c
el
defin
five
mab
epitop
could
group
two
nonoverlap
antigen
site
defin
yewdel
gerhard
antibodi
appear
recogn
apoprotein
el
sinc
bound
well
nonglycosyl
precursor
glycosyl
form
site
c
clearli
distinct
recogn
antibodi
definit
possibl
overlap
epitop
b
antibodi
